Abridge and NACHC Making the Abridge Assistant Available to 108,000 Community Health Center Clinicians
The Abridge Assistant, which provides clinical decision support across more than 300 U.S. health systems, will be available at no cost to NACHC members.
SAN FRANCISCO, CA — November 13, 2026 — Abridge and the National Association of Community Health Centers (NACHC) today announced the Abridge Assistant will be available at no cost to 108,000 clinicians at all NACHC member community health centers. The partnership reflects a shared commitment to expanding access to the latest AI technology, including clinical decision support, to clinicians who provide comprehensive primary care services to around 52 million people in the United States—nearly one in seven Americans and one in three rural residents.
While community health centers strive to reduce barriers to care for patients, the Abridge Assistant aims to reduce barriers for clinicians by enabling them to spend more time on patient care. Clinicians can ask clinical questions and explore medical evidence and guidelines with cited sources from peer-reviewed medical literature and clinical guidelines. The goal is to make everyday clinical and clerical work easier, while keeping clinical judgment and final decisions with the clinician.
“Together with NACHC, we want to make AI more accessible in ways that benefit clinicians, patients, and the communities they serve,” said Shiv Rao, MD, CEO and Co-Founder of Abridge and a practicing cardiologist. “Access is the first step but equity comes from empowering clinicians to use the technology in ways that fits into their existing practice and keeps the needs of patients at the center.”
NACHC members will be able to use the Assistant regardless of whether they use Abridge’s clinical documentation product. With Abridge Assistant, clinicians can:
- Access trusted evidence: Ask about screening guidelines, treatment options, or recommended workups, with cited sources to review.
- Support clinical reasoning: Explore a differential diagnosis, compare medications, or access widely used clinical calculators.
“Our vision is to foster healthy and thriving communities where everyone receives affordable, comprehensive, and effective primary care,” said Sean P. Roddy, EVP and Chief Growth Officer at NACHC. “Community health centers are the nation’s largest primary care network, serving more than 52 million people nationwide. This partnership with Abridge will put practical AI tools within reach of more community health center clinicians, helping them to spend more time focused on their patients.”
See how Abridge Assistant can support community health center workflows. Join our live demo and Q&A on December 3. Or reach out to Sales@abridge.com to get started today.
About Abridge
Founded in 2018, Abridge is the first AI-native clinician intelligence platform organized around the patient, built for clinicians, and designed to help health systems coordinate the clinical, financial, and evidence-based decisions for every moment of care. Powered by purpose-built AI for healthcare, Abridge connects patients, providers, payers, and life sciences companies. This year, the platform will support more than 120 million patient-clinician encounters across more than 300 of the largest and most complex health systems in the U.S. With deep workflow integration, the Abridge clinician intelligence platform has been validated to support encounters in 28+ languages across specialties and care settings.
Abridge is setting the industry standard for the responsible deployment of AI across health systems with continual and transparent AI evaluation. The Abridge Assistant references and cites gold-standard sources of evidence. Features like Linked Evidence map AI-generated documentation and responses to source data, helping clinicians quickly trust and verify the output.
Abridge was awarded Best in KLAS for Ambient AI in 2025 and 2026, in addition to other accolades, including TIME Best Inventions of 2024 and 2025, CNBC Disruptor 2025, and Fast Company's Most Innovative Companies 2025.